IGM Biosciences's market cap is currently ―. The company's EPS TTM is $-4.816; its P/E ratio is -1.49; IGM Biosciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 651.00K	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -60.45M	$ -61.75M	$ -64.31M	$ -59.22M	$ -56.45M
EBITDA	$ -60.26M	$ -61.84M	$ -64.45M	$ -60.05M	$ -56.53M
Net Income Common Stockholders	$ -60.70M	$ -61.99M	$ -64.42M	$ -59.31M	$ -52.58M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 337.68M	$ 386.99M	$ 386.87M	$ 373.40M	$ 427.16M
Total Assets	$ 423.41M	$ 474.35M	$ 480.66M	$ 462.74M	$ 513.50M
Total Debt	$ 40.51M	$ 41.19M	$ 41.42M	$ 41.29M	$ 41.17M
Net Debt	$ -297.17M	$ -345.80M	$ -345.45M	$ -332.10M	$ -385.99M
Total Liabilities	$ 220.18M	$ 220.49M	$ 222.05M	$ 223.31M	$ 226.24M
Stockholders Equity	$ 203.23M	$ 253.86M	$ 258.41M	$ 239.43M	$ 287.26M
Cash Flow	-
Free Cash Flow	$ -49.46M	$ -43.20M	$ -57.02M	$ -54.93M	$ -40.55M
Operating Cash Flow	$ -48.01M	$ -40.12M	$ -53.10M	$ -51.00M	$ -37.86M
Investing Cash Flow	$ -14.69M	$ 19.55M	$ -6.33M	$ 69.82M	$ -18.81M
Financing Cash Flow	$ 402.00K	$ 44.64M	$ 69.95M	$ 75.00K	$ 482.00K

Currency in USD

IGM Biosciences Earnings and Revenue History

Income Statement >

IGM Biosciences Debt to Assets

Balance Sheet >

IGM Biosciences Cash Flow

Cash Flow >

IGM Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing